托尼萘酸与阿托伐他汀联合复方丹参注射液治疗酒精性高脂血症综合征的临床观察OA北大核心CSTPCD
Clinical Observation of Efficacy of Tolynicate and Napthylacetic Acid and Atorvastatin Combined with Dansh-en Injection in the Treatment of Alcoholic Hyperlipemia Syndrome
目的:观察托尼萘酸与阿托伐他汀联合复方丹参注射液治疗酒精性高脂血症综合征的疗效和安全性.方法:21例酒精性高脂血症综合征患者均给予维持酸碱平衡、吸氧等常规治疗,在此基础上,给予托尼萘酸片75 mg,口服,每日3次+阿托伐他汀钙片20 mg,口服,每日1次+复方丹参注射液4 ml,加入5%葡萄糖注射液150 ml中,静脉滴注,每日1次.疗程均为30 d.观察所有患者的临床疗效,治疗前及治疗6、12、18、24、30 d后的丙氨酸氨基转移酶(ALT)…查看全部>>
OBJECTIVE:To obverse the efficacy and safety of tolynicate and napthylacetic acid and atorvastation combined with Danshen injection in the treatment of alcoholic hyperlipemia syndrome. METHODS:21 patients with alcoholic hyperlipemia syndrome were enrolled. All patients were given maintaining acid-base balance,oxygen inhalation and other conventional treatment. Based on it,they were orally given 75 mg Tolynicate and napthylacetic acid tablet,3 times a day+20 …查看全部>>
姜琼;陈胜鹏;程正位
咸宁市中心医院药剂科,湖北咸宁 437100咸宁市中心医院法医鉴定所,湖北咸宁 437100咸宁市中心医院消化内科,湖北咸宁 437100
医药卫生
托尼萘酸阿托伐他汀复方丹参注射液酒精性高脂血症综合征
Tolynicate and napthylacetic acidAtorvastatinDanshen injectionAlcoholic hyperlipemia syndrome
《中国药房》 2016 (3)
中国儿童合理用药评价指标体系的循证研究
332-334,3
国家自然科学基金资助项目(No.81373381)
评论